Theranos blood-testing lab poses 'immediate' risk – US government
by Nicky Woolf in San Francisco from Technology | The Guardian on (#122KX)
'Immediate corrective action' is needed at the blood-testing firm's California lab, a health agency has told the Silicon Valley unicorn
Theranos has been hit with yet another major setback after a US government health agency described its blood-testing technology as posing "immediate jeopardy" to the public.
The Silicon Valley firm has been valued at $10bn, raising $400m from investors through what it claimed was "breakthrough" technology that allowed it to do blood tests based on a pinprick, rather than a full blood draw.
Continue reading...